Browser does not support script.
We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.
Scientists win award to tackle hard to treat cancers
Scientists closer to understanding the role of certain genes in breast cancer
New molecular mechanism revealed for genetic mutations in aggressive cancer cells
Scientists set to benefit from one of the biggest grants awarded by Cancer Research UK
Life Sciences in Six - Dr Joanna Parish
My story: Graham Silk
Posted 11 June 2018
University of Birmingham researchers are leading the way with a ground-breaking role to enable more children with the rare cancer neuroblastoma to access potentially life-saving clinical trials more quickly.
Posted 08 June 2018
The Institute of Cancer and Genomic Sciences recently appointed Professor Colin Watts as Chair of the Birmingham Brain Cancer Programme. He joins Birmingham from the University of Cambridge, bringing with him over 25 years of clinical experience,
Posted 31 May 2018
A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance, a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) Network based at University of Birmingham.
View all news